Aandelen in “Biotechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
30/10 | 2,460 USD
-1,99% |
-1,99% |
|
Cabaletta Bio Inc |
31/10 | 3,610 USD
+46,15% |
+46,15% |
|
Calithera Biosciences Inc |
30/10 | 0,000 USD
0,00% |
0,00% |
|
Can-Fite Biopharma Ltd |
30/10 | 0,430 USD
-2,16% |
-2,16% |
|
Capricor Therapeutics Inc |
31/10 | 6,510 USD
+4,83% |
+4,83% |
Carbios |
30/10 | 7,080 EUR
-4,58% |
-4,58% |
|
Carisma Therapeutics, Inc. |
31/10 | 0,052 USD
-10,43% |
-10,43% |
|
CASI Pharmaceuticals Inc |
30/10 | 1,360 USD
-4,23% |
-4,23% |
|
Cel-Sci Corp. |
31/10 | 7,090 USD
+6,78% |
+6,78% |
|
Celldex Therapeutics Inc. |
31/10 | 26,730 USD
+2,81% |
+2,81% |
|
Cellectar Biosciences Inc |
31/10 | 3,390 USD
+3,99% |
+3,99% |
|
Cellectis |
31/10 | 3,085 EUR
+0,98% |
+0,98% |
|
Cellectis |
30/10 | 3,480 USD
-4,13% |
-4,13% |
Celyad Oncology |
31/10 | 0,201 EUR
0,00% |
0,00% |
|
Champions Oncology Inc |
30/10 | 6,810 USD
+0,74% |
+0,74% |
|
Cidara Therapeutics Inc |
31/10 | 109,240 USD
+0,19% |
+0,19% |
|
Co-Diagnostics Inc |
31/10 | 0,460 USD
-1,75% |
-1,75% |
|
Cogent Biosciences Inc |
30/10 | 16,210 USD
+1,31% |
+1,31% |
|
Coherus Biosciences Inc |
31/10 | 1,680 USD
-1,18% |
-1,18% |
|
CollPlant Biotechnologies Ltd |
30/10 | 2,190 USD
-0,45% |
-0,45% |
|
Compass Pathways Plc |
31/10 | 6,320 USD
+0,32% |
+0,32% |
|
Compugen Ltd. |
31/10 | 1,770 USD
+7,27% |
+7,27% |
|
Corbus Pharmaceuticals Holdings Inc |
30/10 | 16,440 USD
-2,49% |
-2,49% |
|
CRISPR Therapeutics AG |
31/10 | 63,990 USD
+4,73% |
+4,73% |
|
Cue Biopharma Inc |
30/10 | 0,699 USD
+1,36% |
+1,36% |
|
Curis Inc |
31/10 | 1,490 USD
0,00% |
0,00% |
|
Cyclacel Pharmaceuticals Inc |
24/10 | 5,800 USD
+8,82% |
+8,82% |
|
Cyclacel Pharmaceuticals Inc |
30/10 | 1,820 USD
+1,11% |
+1,11% |
|
Cytokinetics Inc |
31/10 | 63,590 USD
+2,15% |
+2,15% |
|
CytomX Therapeutics Inc |
30/10 | 3,330 USD
+2,15% |
+2,15% |